sameAs
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifenZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumJARID1B is a luminal lineage-driving oncogene in breast cancerRegulation of p53 tetramerization and nuclear export by ARCZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PMLExpression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteinsEEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemiaDifferential oestrogen receptor binding is associated with clinical outcome in breast cancerPREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerBCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedInternational network of cancer genome projects.Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expressionThe NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor geneMicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeGermline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteriaExpression microarray reproducibility is improved by optimising purification steps in RNA amplification and labellingDifferential gene expression profile in the small intestines of mice lacking pacemaker interstitial cells of CajalMolecular profiling of breast cancer: portraits but not physiognomy.Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it?Differential gene expression in the murine gastric fundus lacking interstitial cells of CajalHuman and mouse oligonucleotide-based array CGH.Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapiesMaintaining Tumor Heterogeneity in Patient-Derived Tumor XenograftsProgesterone receptor modulates ERα action in breast cancer.MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell linesEMSY links the BRCA2 pathway to sporadic breast and ovarian cancerLoss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerAberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumoursSmall molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesGenetic unmasking of an epigenetically silenced microRNA in human cancer cellsFrequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaA prognostic gene signature for metastasis-free survival of triple negative breast cancer patientsThe Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyFacilitating a culture of responsible and effective sharing of cancer genome dataToward understanding and exploiting tumor heterogeneityA genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagusSignatures of mutational processes in human cancerThe landscape of cancer genes and mutational processes in breast cancerThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
P50
Q21195205-6D33178A-6697-4CA2-B6D9-074E970CED71Q24293658-08A245FC-61AB-49A1-8C10-DF822965E017Q24299326-E3946131-25AB-4394-AAE9-E9B3DB6E8910Q24304068-EAAE24A4-6471-4B3E-B22E-947C998838AEQ24306219-799ED5AD-8808-461E-B6A4-8F585CE71686Q24532055-ADFCAABE-7104-4CCF-9AC9-4B3E19785DDBQ24564948-2DD62CD1-DC0B-4986-8BD6-4896778A4DA6Q24595511-449DA038-24BF-4A33-9447-AB802D23AFB3Q24600928-942E2E91-DC82-4D03-A462-A97E8876A055Q24610409-C756CDF9-9362-4A9A-AA69-1E085F394BA2Q24611474-170AF4CA-6EB8-4BB4-9725-8F661E7076D1Q24611474-438DFF2F-6CFC-4E70-A8B9-B9DCBFE561EDQ24634173-1FF7B441-B87C-49C9-84A7-B0B25EC507B0Q24645371-B7F65770-1650-495D-8545-BE72B4AB4439Q24646090-3D1F05DC-2AB8-43CB-8C9A-05562D143C56Q24675276-EA0B51C6-BEB7-4B57-A70F-308E181CA04CQ24796914-0383E17E-EF26-4CB7-998D-B917438DC684Q24800733-1F7940A5-E278-4A9C-BD59-306D7E694066Q24801259-E3CEE0BA-5779-4341-94EC-8202342F2457Q24804625-058DC2B0-E6BD-4538-91AA-860CCDF1730EQ24805255-D9627D2A-EA1F-4566-8E95-A4139CC00192Q24813019-214B6760-35EF-48C6-AEF4-5C9D2EFFE39DQ26770133-9B155A95-D89A-4AEB-AA65-2D0FA3F76DB0Q26801063-19EDEDB7-C9EF-4FD6-B5E2-DA1297CECAF8Q27316268-727538D1-7E58-4458-993D-0C69814EFD69Q28142772-224F627F-B1AB-4CA7-95AE-3584A781A4E9Q28188794-D0E23EE1-111A-4211-B837-70A95D7DAE75Q28239595-09022F56-FC96-4F2E-84B4-92AEFF486FB4Q28254359-EFCD74D3-FD0D-4D11-97AC-CF8DDF508472Q28261026-C0E3902F-822B-49F7-B97E-B51650BCC30FQ28275430-7AF414A2-B451-4B7D-96B6-8A9003162CEDQ28288806-2D4E6A42-5D37-4EDD-BF1B-C8A6BBC7EBCFQ28300339-6308289F-5AAF-4AD9-A872-2D64BB6806E9Q28536791-7CE4C232-E401-4B7D-819E-F093EAAEAEF5Q28552519-D599FBF7-02D7-4EE3-9DD4-02588220C357Q28597289-F094B4CD-5B7B-4357-8932-CB4D3D5F5C3FQ28603034-981AA3F9-11E4-4FAF-AB81-D21F7624FCB4Q28943522-ABF7B2E3-FFD5-44A8-9830-728B3803C758Q29547191-00AA8B50-CFB8-48AF-AEE5-0ACE849D6B04Q29614637-494E7DB3-4DE1-42F1-B684-EE6FD48000D6
P50
description
Portugees arts
@nl
clinician scientist and Senior ...... itute, University of Cambridge
@en
dokter asal Portugal
@id
médicu portugués
@ast
portugiesischer Arzt
@de
հետազոտող
@hy
طبيب برتغالي
@ar
name
Carlos Caldas
@ast
Carlos Caldas
@da
Carlos Caldas
@de
Carlos Caldas
@en
Carlos Caldas
@es
Carlos Caldas
@fr
Carlos Caldas
@ga
Carlos Caldas
@it
Carlos Caldas
@nb
Carlos Caldas
@nl
type
label
Carlos Caldas
@ast
Carlos Caldas
@da
Carlos Caldas
@de
Carlos Caldas
@en
Carlos Caldas
@es
Carlos Caldas
@fr
Carlos Caldas
@ga
Carlos Caldas
@it
Carlos Caldas
@nb
Carlos Caldas
@nl
altLabel
Caldas C
@en
Carlos caldas
@pt
prefLabel
Carlos Caldas
@ast
Carlos Caldas
@da
Carlos Caldas
@de
Carlos Caldas
@en
Carlos Caldas
@es
Carlos Caldas
@fr
Carlos Caldas
@ga
Carlos Caldas
@it
Carlos Caldas
@nb
Carlos Caldas
@nl
P106
P21
P27
P31
P496
0000-0003-3547-1489
P5008
P569
1960-06-26T00:00:00Z